Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma, CANbridge Pharma 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma
NCT05422482: A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ

Active, not recruiting
1
12
RoW
GC1123
GC Biopharma Corp
Mucopolysaccharidosis II, Hunter Syndrome
06/27
06/27

Download Options